MURALIDHAR PREMKUMAR to Fat Emulsions, Intravenous
This is a "connection" page, showing publications MURALIDHAR PREMKUMAR has written about Fat Emulsions, Intravenous.
Connection Strength
2.792
-
Patterns of lipid-injectable emulsion use in neonatal intensive care units across the United States: A multi-institution survey. JPEN J Parenter Enteral Nutr. 2023 01; 47(1):51-58.
Score: 0.773
-
A Neonatologist's Perspective: Is the Quest for an "Ideal" Lipid Emulsion Over? JPEN J Parenter Enteral Nutr. 2018 01; 42(1):12-13.
Score: 0.562
-
Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience. Adv Nutr. 2014 Jan 01; 5(1):65-70.
Score: 0.428
-
Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness study. JPEN J Parenter Enteral Nutr. 2025 Feb; 49(2):180-188.
Score: 0.229
-
Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events. J Pediatr. 2022 02; 241:173-180.e1.
Score: 0.184
-
Parenteral lipid emulsions induce unique ileal fatty acid and metabolomic profiles but do not increase the risk of necrotizing enterocolitis in preterm pigs. Am J Physiol Gastrointest Liver Physiol. 2021 02 01; 320(2):G227-G239.
Score: 0.173
-
Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study. J Pediatr. 2021 03; 230:46-54.e2.
Score: 0.171
-
Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates. Nutr Clin Pract. 2017 Jun; 32(3):326-336.
Score: 0.132
-
High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr. 2013 Apr; 162(4):793-798.e1.
Score: 0.099
-
Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease. J Pediatr. 2020 04; 219:98-105.e4.
Score: 0.041